About | Sofinnova

Sofinnova: At the Intersection of Life Science, Finance & Innovation

Since our founding in 1976, Sofinnova has been active in life science investing and has primarily focused on therapeutic drugs over the last decade. We are a healthcare investment firm with approximately $3.0B in assets under management and committed capital.* We invest in both private and public equity companies.

Our Mission: to improve the lives of patients through science. We strive to provide outstanding results for those we serve: patients, entrepreneurs, and the investors that entrust us with their capital.

Historically Helping

We are long-term investors with an extensive track record of helping the world’s most transformative therapies come to fruition. From drug development and navigating the regulatory process to company building and IPO, we strive to be collaborative, meaningful board members, and excellent partners at every level.

Experience, Collaborative Team

Competitive Track Record

Deep Industry Knowledge

Exploring Possibilities

Sofinnova invests in late preclinical and clinical therapeutic companies across the U.S. and Europe. Key therapeutic areas include oncology, respiratory, dermatology, ophthalmology, neurology and women’s health. We actively partner with entrepreneurs in both the U.S. and Europe who want to rewrite the quality of healthcare today for a better life tomorrow.

1972

Sofinnova was founded with the backing of several French financial institutions in Paris, France

1976

Sofinnova opened a San Francisco, Ca office

1997

The global Sofinnova organization was restructured and became two separate management companies, one for Sofinnova Ventures based in the US and one for Sofinnova Partners based in Paris, France

1998

Raised Sofinnova Venture Partners IV – Broad Life Science & IT

2000

Raised Sofinnova Venture Partners V - Broad Life Science & IT

2003

Raised Sofinnova Venture Partners VI – Broad Life Science & IT

2006

Raised Sofinnova Venture Partners VII – Primarily focused on Therapeutics

2009

Sofinnova opened an office in La Jolla, Ca

2011

Sofinnova opened the new headquarters on Sand Hill Road in Menlo Park, Ca

2011

Raised Sofinnova Venture Partners VIII - Focused Therapeutics

2014

Raised Sofinnova Venture Partners IX - Focused Therapeutics

2016

Raised our largest fund to date, Sofinnova Ventures Partners X at $650M

2017

Sofinnova launched a public equity strategy focused on global therapeutics

Passionate people make the difference.

We are believers, thinkers, disruptors, and collaborators. Let’s break new boundaries in healthcare together.

Meet Our Team